Linden Advisors’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-498,000
| Closed | -$5.03M | – | 564 |
|
|
2022
Q4 | $5.03M | Hold |
498,000
| – | – | 0.05% | 208 |
|
|
2022
Q3 | $4.94M | Hold |
498,000
| – | – | 0.05% | 230 |
|
|
2022
Q2 | $4.87M | Hold |
498,000
| – | – | 0.04% | 250 |
|
|
2022
Q1 | $4.86M | Hold |
498,000
| – | – | 0.03% | 342 |
|
|
2021
Q4 | $4.83M | Hold |
498,000
| – | – | 0.03% | 312 |
|
|
2021
Q3 | $4.84M | Hold |
498,000
| – | – | 0.03% | 311 |
|
|
2021
Q2 | $4.81M | Buy |
+498,000
| New | +$4.81M | 0.03% | 342 |
|